Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature

Arthritis Care and Research

Volumn 65, Issue 11, 2013, Pages 1869-1873

  Andreoli, Laura ^a   Chighizola, Cecilia B ^b   Banzato, Alessandra ^c   Pons Estel, Guillermo J ^d   De Jesus, Guilherme Ramire ^e   Erkan, Doruk ^f  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d HOSPITAL CLÍNIC   (Spain)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; BIRTH WEIGHT; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ECLAMPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS MALFORMATION; HEART INFARCTION; HELLP SYNDROME; HUMAN; MORBIDITY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; REVIEW; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; MORBIDITY; MYOCARDIAL INFARCTION; PREGNANCY; PREGNANCY COMPLICATIONS; STROKE; VENOUS THROMBOSIS; WORLD HEALTH;

EID: 84887112232     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22066     Document Type: Review

References (12)

1. Meroni PL, Borghi MO, Raschi E, Tedesco F,. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011; 7: 330-9.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
3. Erkan D, Derksen R, Levy R, Machin S, Ortel T, Pierangeli S, et al. Antiphospholipid Syndrome Clinical Research Task Force report. Lupus 2011; 20: 219-24.
4. Erkan D, Lockshin MD, for the APS ACTION members. APS ACTION: AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. Lupus 2012; 21: 695-8.
5. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
6. Macklon NS, Geraedts JP, Fauser BC,. Conception to ongoing pregnancy: the "black box" of early pregnancy loss. Hum Reprod Update 2002; 8: 333-43.
7. Stephenson MD,. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66: 24-9.
8. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews TJ, et al. Births: final data for 2009. Natl Vit Stat Rep 2011; 60: 1-70.
9. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB,. Executive summary: heart disease and stroke statistics, 2012 update. A report from the American Heart Association. Circulation 2012; 125: 188-97.
10. White RH,. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8.
11. United States Census. 2010 census data products. URL: www.census.gov/population/www/cen2010/glance/index.html.
12. Pierangeli SS, de Groot PG, Dlott J, Favaloro E, Harris EN, Lakos G, et al. "Criteria" aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus 2011; 20: 182-90.